Literature DB >> 24100690

Cell-cell adhesion genes CTNNA2 and CTNNA3 are tumour suppressors frequently mutated in laryngeal carcinomas.

Miriam Fanjul-Fernández1, Víctor Quesada, Rubén Cabanillas, Juan Cadiñanos, Tania Fontanil, Alvaro Obaya, Andrew J Ramsay, José L Llorente, Aurora Astudillo, Santiago Cal, Carlos López-Otín.   

Abstract

Laryngeal squamous cell carcinoma is a frequent and significant cause of morbidity and mortality. Here we explore the biological basis of this aggressive tumour, and identify two cell-cell adhesion genes as recurrently mutated in this malignancy. We first perform exome sequencing of four laryngeal carcinomas and their matched normal tissues. Among the 569 genes found to present somatic mutations, and based on their recurrence or functional relevance in cancer, we select 40 for further validation in 86 additional laryngeal carcinomas. We detect frequent mutations (14 of 90, 15%) in CTNNA2 and CTNNA3-encoding α-catenins. Functional studies reveal an increase in the migration and invasive ability of head and neck squamous cell carcinoma cells producing mutated forms of CTNNA2 and CTNNA3 or in cells where both α-catenins are silenced. Analysis of the clinical relevance of these mutations demonstrates that they are associated with poor prognosis. We conclude that CTNNA2 and CTNNA3 are tumour suppressor genes frequently mutated in laryngeal carcinomas.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24100690     DOI: 10.1038/ncomms3531

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  40 in total

1.  Cadherins in tissue architecture and disease.

Authors:  Dietmar Vestweber
Journal:  J Mol Med (Berl)       Date:  2014-12-10       Impact factor: 4.599

Review 2.  Prevalence of EGFR Tyrosine Kinase Domain Mutations in Head and Neck Squamous Cell Carcinoma: Cohort Study and Systematic Review.

Authors:  Christos Perisanidis
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

3.  MiRNA-mRNA crosstalk in laryngeal squamous cell carcinoma based on the TCGA database.

Authors:  Guan-Jiang Huang; Meng-Si Luo; Guo-Ping Chen; Min-Yi Fu
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-01-13       Impact factor: 2.503

4.  Identification of subsets of actionable genetic alterations in KRAS-mutant lung cancers using association rule mining.

Authors:  Junior Tayou
Journal:  Cell Oncol (Dordr)       Date:  2018-04-20       Impact factor: 6.730

Review 5.  Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.

Authors:  M Giefing; M Wierzbicka; K Szyfter; J C Brenner; B J Braakhuis; R H Brakenhoff; C R Bradford; J A Sorensen; A Rinaldo; J P Rodrigo; R P Takes; A Ferlito
Journal:  Eur J Cancer       Date:  2016-02-04       Impact factor: 9.162

Review 6.  New functions for alpha-catenins in health and disease: from cancer to heart regeneration.

Authors:  Alexia Vite; Jifen Li; Glenn L Radice
Journal:  Cell Tissue Res       Date:  2015-02-12       Impact factor: 5.249

Review 7.  Ion Channel Dysregulation in Head and Neck Cancers: Perspectives for Clinical Application.

Authors:  Nagore Del-Río-Ibisate; Rocío Granda-Díaz; Juan P Rodrigo; Sofía T Menéndez; Juana M García-Pedrero
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

8.  Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer.

Authors:  Hui Zhang; Tao Liu; Zhen Zhang; Samuel H Payne; Bai Zhang; Jason E McDermott; Jian-Ying Zhou; Vladislav A Petyuk; Li Chen; Debjit Ray; Shisheng Sun; Feng Yang; Lijun Chen; Jing Wang; Punit Shah; Seong Won Cha; Paul Aiyetan; Sunghee Woo; Yuan Tian; Marina A Gritsenko; Therese R Clauss; Caitlin Choi; Matthew E Monroe; Stefani Thomas; Song Nie; Chaochao Wu; Ronald J Moore; Kun-Hsing Yu; David L Tabb; David Fenyö; Vineet Bafna; Yue Wang; Henry Rodriguez; Emily S Boja; Tara Hiltke; Robert C Rivers; Lori Sokoll; Heng Zhu; Ie-Ming Shih; Leslie Cope; Akhilesh Pandey; Bing Zhang; Michael P Snyder; Douglas A Levine; Richard D Smith; Daniel W Chan; Karin D Rodland
Journal:  Cell       Date:  2016-06-29       Impact factor: 41.582

Review 9.  Emerging Contributions of Cancer/Testis Antigens to Neoplastic Behaviors.

Authors:  Zane A Gibbs; Angelique W Whitehurst
Journal:  Trends Cancer       Date:  2018-09-20

10.  Clonal status of actionable driver events and the timing of mutational processes in cancer evolution.

Authors:  Nicholas McGranahan; Francesco Favero; Elza C de Bruin; Nicolai Juul Birkbak; Zoltan Szallasi; Charles Swanton
Journal:  Sci Transl Med       Date:  2015-04-15       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.